These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Treatment of lower respiratory tract infections with cefoperazone. Kaplowitz LG; Sarubbi FA Clin Ther; 1983; 5(3):243-50. PubMed ID: 6221798 [TBL] [Abstract][Full Text] [Related]
7. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430 [TBL] [Abstract][Full Text] [Related]
8. A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli. Warren JW; Miller EH; Fitzpatrick B; DiFranco DE; Caplan ES; Tenney JH; Anthony WC Rev Infect Dis; 1983; 5 Suppl 1():S173-80. PubMed ID: 6221388 [TBL] [Abstract][Full Text] [Related]
9. Multicentered study of cefoperazone for treatment of intraabdominal infections and comparison of cefoperazone with cefamandole and clindamycin plus gentamicin for treatment of appendicitis and peritonitis. Baird IM Rev Infect Dis; 1983; 5 Suppl 1():S165-72. PubMed ID: 6221387 [TBL] [Abstract][Full Text] [Related]
10. [Double-blind comparison of cefamandole and cefazolin in the therapy of respiratory tract infections (author's transl)]. Jpn J Antibiot; 1980 Mar; 33(3):375-409. PubMed ID: 6995640 [TBL] [Abstract][Full Text] [Related]
11. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)]. Ikemoto H; Ito C; Yoshida T; Watanabe K; Mori T; Ohno I; Okada S; Igari J; Arakawa M; Igarashi K; Oguri T; Okada M; Ozaki K; Terai T; Aoki N; Inoue H; Nakadate T; Kitamura N; Sekine O; Suzuki Y; Ando M; Suga M; Sato K; Nakata K; Kusano N Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048 [TBL] [Abstract][Full Text] [Related]
12. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)]. Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Tanimoto H; Nakata K; Nakamori Y; Nakatani T; Kusano N Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305 [TBL] [Abstract][Full Text] [Related]
13. A comparison of cefotaxime and cefoperazone in respiratory tract infections. Garcia-Rodriguez JA; Gomez-Garcia AC J Antimicrob Chemother; 1984 Sep; 14 Suppl B():301-6. PubMed ID: 6094456 [TBL] [Abstract][Full Text] [Related]
14. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials. Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462 [TBL] [Abstract][Full Text] [Related]
15. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections]. Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054 [TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of cefoperazone in lower respiratory tract infections]. Ishibashi T; Takamoto M; Shinoda A; Matsuba K; Yoshida M; Ichikawa Y; Ando M; Matsuzaki Y; Kitahara Y; Hara N Jpn J Antibiot; 1986 Oct; 39(10):2780-94. PubMed ID: 3543433 [TBL] [Abstract][Full Text] [Related]